These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 10909603

  • 21. [Gene therapy of monogenic hereditary diseases. Duchenne myodystrophy].
    Baranov VS, Baranov AN.
    Vopr Med Khim; 2000; 46(3):279-92. PubMed ID: 11033887
    [Abstract] [Full Text] [Related]

  • 22. Codon optimization of the microdystrophin gene for Duchene muscular dystrophy gene therapy.
    Athanasopoulos T, Foster H, Foster K, Dickson G.
    Methods Mol Biol; 2011; 709():21-37. PubMed ID: 21194019
    [Abstract] [Full Text] [Related]

  • 23. Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping.
    Goyenvalle A, Vulin A, Fougerousse F, Leturcq F, Kaplan JC, Garcia L, Danos O.
    Science; 2004 Dec 03; 306(5702):1796-9. PubMed ID: 15528407
    [Abstract] [Full Text] [Related]

  • 24. Harnessing the potential of dystrophin-related proteins for ameliorating Duchenne's muscular dystrophy.
    Krag TO, Gyrd-Hansen M, Khurana TS.
    Acta Physiol Scand; 2001 Mar 03; 171(3):349-58. PubMed ID: 11412148
    [Abstract] [Full Text] [Related]

  • 25. Dystrophin and utrophin: genetic analyses of their role in skeletal muscle.
    Rafael JA, Brown SC.
    Microsc Res Tech; 2001 Mar 03; 48(3-4):155-66. PubMed ID: 10679963
    [Abstract] [Full Text] [Related]

  • 26. Electroporation of corrective nucleic acids (CNA) in vivo to promote gene correction in dystrophic muscle.
    Kapsa RM, Wong SH, Quigley AF.
    Methods Mol Biol; 2008 Mar 03; 423():405-19. PubMed ID: 18370218
    [Abstract] [Full Text] [Related]

  • 27. Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy.
    Harper SQ, Hauser MA, DelloRusso C, Duan D, Crawford RW, Phelps SF, Harper HA, Robinson AS, Engelhardt JF, Brooks SV, Chamberlain JS.
    Nat Med; 2002 Mar 03; 8(3):253-61. PubMed ID: 11875496
    [Abstract] [Full Text] [Related]

  • 28. A highly functional mini-dystrophin/GFP fusion gene for cell and gene therapy studies of Duchenne muscular dystrophy.
    Li S, Kimura E, Ng R, Fall BM, Meuse L, Reyes M, Faulkner JA, Chamberlain JS.
    Hum Mol Genet; 2006 May 15; 15(10):1610-22. PubMed ID: 16595609
    [Abstract] [Full Text] [Related]

  • 29. The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies.
    Banks GB, Chamberlain JS.
    Curr Top Dev Biol; 2008 May 15; 84():431-53. PubMed ID: 19186250
    [Abstract] [Full Text] [Related]

  • 30. Protein-Anchoring Therapy of Biglycan for Mdx Mouse Model of Duchenne Muscular Dystrophy.
    Ito M, Ehara Y, Li J, Inada K, Ohno K.
    Hum Gene Ther; 2017 May 15; 28(5):428-436. PubMed ID: 27485975
    [Abstract] [Full Text] [Related]

  • 31. Autotransplantation in mdx mice of mdx myoblasts genetically corrected by an HSV-1 amplicon vector.
    Bujold M, Caron N, Camiran G, Mukherjee S, Allen PD, Tremblay JP, Wang Y.
    Cell Transplant; 2002 May 15; 11(8):759-67. PubMed ID: 12588108
    [Abstract] [Full Text] [Related]

  • 32. Improvement in survival and muscle function in an mdx/utrn(-/-) double mutant mouse using a human retinal dystrophin transgene.
    Gaedigk R, Law DJ, Fitzgerald-Gustafson KM, McNulty SG, Nsumu NN, Modrcin AC, Rinaldi RJ, Pinson D, Fowler SC, Bilgen M, Burns J, Hauschka SD, White RA.
    Neuromuscul Disord; 2006 Mar 15; 16(3):192-203. PubMed ID: 16487708
    [Abstract] [Full Text] [Related]

  • 33. Full-length dystrophin gene transfer to the mdx mouse in utero.
    Reay DP, Bilbao R, Koppanati BM, Cai L, O'Day TL, Jiang Z, Zheng H, Watchko JF, Clemens PR.
    Gene Ther; 2008 Apr 15; 15(7):531-6. PubMed ID: 18273052
    [Abstract] [Full Text] [Related]

  • 34. Induction of dystrophin expression by exon skipping in mdx mice following intramuscular injection of antisense oligonucleotides complexed with PEG-PEI copolymers.
    Williams JH, Sirsi SR, Latta DR, Lutz GJ.
    Mol Ther; 2006 Jul 15; 14(1):88-96. PubMed ID: 16488666
    [Abstract] [Full Text] [Related]

  • 35. Systemic human minidystrophin gene transfer improves functions and life span of dystrophin and dystrophin/utrophin-deficient mice.
    Wang B, Li J, Fu FH, Xiao X.
    J Orthop Res; 2009 Apr 15; 27(4):421-6. PubMed ID: 18973234
    [Abstract] [Full Text] [Related]

  • 36. Efficient and fast functional screening of microdystrophin constructs in vivo and in vitro for therapy of duchenne muscular dystrophy.
    Jørgensen LH, Larochelle N, Orlopp K, Dunant P, Dudley RW, Stucka R, Thirion C, Walter MC, Laval SH, Lochmüller H.
    Hum Gene Ther; 2009 Jun 15; 20(6):641-50. PubMed ID: 19239382
    [Abstract] [Full Text] [Related]

  • 37. [Development of new therapy on muscular dystrophy].
    Takeda S.
    Rinsho Shinkeigaku; 2001 Dec 15; 41(12):1154-6. PubMed ID: 12235824
    [Abstract] [Full Text] [Related]

  • 38. [Adeno-associated virus vector carrying human minidystrophin gene SMCKA3999 effectively ameliorates dystrophic pathology in mdx model mice].
    Li HH, Zhang SM, Fang SY, Chen CL, Luo YD, Guan Y, Wang DW, Xiao X.
    Zhonghua Yi Xue Za Zhi; 2003 Sep 10; 83(17):1513-6. PubMed ID: 14521733
    [Abstract] [Full Text] [Related]

  • 39. Stable fetal cardiomyocyte grafts in the hearts of dystrophic mice and dogs.
    Koh GY, Soonpaa MH, Klug MG, Pride HP, Cooper BJ, Zipes DP, Field LJ.
    J Clin Invest; 1995 Oct 10; 96(4):2034-42. PubMed ID: 7560097
    [Abstract] [Full Text] [Related]

  • 40. Differential distribution of the members of the dystrophin glycoprotein complex in mouse retina: effect of the mdx(3Cv) mutation.
    Dalloz C, Claudepierre T, Rodius F, Mornet D, Sahel J, Rendon A.
    Mol Cell Neurosci; 2001 May 10; 17(5):908-20. PubMed ID: 11358487
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.